Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Circulating RNA Molecules: A New Class of Potential Biomarkers"
Deadline for manuscript submissions: 31 May 2020.
Interests: RNA biology; regulatory RNA molecules; muscle regeneration, identification of genetic defects in inherited diseases
Special Issues and Collections in MDPI journals
Special Issue in Molecules: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
Special Issue in Pharmaceuticals: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
Special Issue in Pharmaceuticals: Chemically Modified Antisense Oligonucleotides: Promising Tools for the Therapy of Diseases
Biomarkers are measurable indicators of normal or pathogenic conditions or pharmacological responses to a therapeutic intervention. Different types of biomarkers have been defined and classified based on their use. More specifically, diagnostic, monitoring, prognostic, and pharmacodynamic/response biomarkers have been recorded. Diagnostic biomarkers are used to identify individuals with a disease or condition of interest, or to define a subset of the disease. Prognostic biomarkers are used to detect the possibility of a clinical symptom, disease recurrence, or disease progression. Monitoring biomarkers are used to regularly screen the patients for a change in the degree or extent of disease. Pharmacodynamic/response biomarkers are used to evaluate the response of the patient to a therapeutic intervention. In blood, circulating biomarkers can exist in the form of DNA, RNA, protein, metabolites, or other molecules. In current years, because of the new high-throughput technologies, RNA circulating biomarkers have gained interest, and hold great promise for their potential use in clinical practise.
The focus of this Special Issue is on the RNA molecules in blood circulation, and their potential use as biomarkers. This Special Issue will include original research articles and review articles on all of the types of RNA molecules circulating in blood, their correlation with a disease state, their classification as specific types of biomarkers, evaluation studies, and new advances in technologies for their identification and evaluation.
Prof. Dr. Leonidas A. Phylactou
Dr. Andrie Koutsoulidou
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Long-non coding RNA
- Circular RNA
- Extracellular RNA
- Exosomal RNA